ImpriMed, a precision medicine company, announced that it has expanded its services to include human oncology.
The aim is to provide drug-response predictions for routine blood cancers such as newly diagnosed multiple myeloma and acute myeloid leukemia.
ImpriMed's human precision medicine services will set their sights on complex blood cancers via a combination of genomic analysis, ex vivo drug...
Hackensack Meridian Health announced it launched a cancer risk and early detection program at the health system’s Hennessy Institute for Cancer Prevention and Applied Molecular Medicine in partnership with oncology-focused precision health technology company CancerIQ, aimed at improving early diagnosis, treatment and prevention.
The program integrates advanced technology, genomics and AI into...
Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round.
Hikma Pharmaceuticals' venture capital arm, Hikma Ventures, participated in the round alongside Novartis (dRx Capital) and Intermountain Ventures. Existing investors Echo Health Ventures, Deerfield...
Healthcare data company ConcertAI announced its expanded partnership with Caris Life Sciences, where the companies will jointly create a database to generate insights to advance precision medicine, clinical trial management and therapeutic development.
ConcertAI is a real-world data and AI company for healthcare providers and life science companies, while Caris Life Sciences offers whole exome...
CHICAGO – Implementing precision medicine programs could allow health systems to diagnose disease more quickly or predict a patient's response to a specific mediation, said panelists at the 2023 HIMSS Global Health Conference & Exhibition.
But there are challenges to putting together an effective genomics program, said Jackie Rice, vice president for information technology and chief...
Health research platform maker Vibrent Health announced last week that it has received a $39 million infusion from the National Institutes of Health to continue serving as the hub of the public research organization's All of Us Research Program.
Founded in 2009, Vibrent Health's technology handles large-scale data collection, storage, analysis and security for research organizations, and includes...
Sema4, a Mount Sinai spinout developing health-data-analytics platforms, has raised $121 million in Series C funding. BlackRock led the oversubscribed round, which also saw participation from new investors Deerfield Management Company and Moore Strategic Ventures, and also old backers Blackstone, Section 32, Oak HC/FT, Decheng and Connecticut Innovations.
With this round, coming less than a year...
By
PsychU
03:02 pm
April 7, 2020
A group of organizations—Amazon, Apple, and Google among others—are blurring the line between the tech field and the healthcare field. One of the key elements in this blurring of the line is the automation of health and human service functions that previously required human work.
This tech-enabled automation is frequently accomplished through bots, which are computer applications that perform...
Astronauts face a myriad of health challenges in space, including exposure to radiation, risk of bone deterioration, vestibular issues and various other concerns.
Space health researchers are continuously looking for ways to prevent and treat medical problems before they arise. Enter precision medicine: an increasingly popular strategy that consider specific variations in a patient’s genetic...
Integrated medication dosing platform InsightRX has closed a $10 million Series A funding round headed by HealthX Ventures. Other participants in the round included Rock Health, OSF Healthcare, Leawood Venture Capital and Premier Inc., as well as returning backer GreatPoint Ventures.
According to the announcement, this brings the company’s total backing to $13 million.
WHAT THEY DO
Founded in...
